Development of a Bilayer Mutual Tablet of Candesartan and Pioglitazone for Diabetic-Hypertensive Patients
Development of a Bilayer Mutual Tablet of Candesartan and Pioglitazone for Diabetic-Hypertensive Patients

Kola Hephzibah; Sangeetha Shanmugasundaram

Volume 6, Issue 7 , July 2023, , Pages 1517-1536

https://doi.org/10.26655/JMCHEMSCI.2023.7.5

Abstract
  Background: Diabetes and hypertension are related illnesses that often coexist. Angiotensin receptor blockers like candesartan are typically used to treat Hypertension. A thiazolidinedione-type ...  Read More
Anti-Atherosclerotic Effects of Pioglitazon by Interference with Inflammatory and Stress Pathway in Male Rabbits
Anti-Atherosclerotic Effects of Pioglitazon by Interference with Inflammatory and Stress Pathway in Male Rabbits

Hajar Nazar Hashem; Fadhil A. Rizij

Volume 6, Issue 4 , April 2023, , Pages 746-754

https://doi.org/10.26655/JMCHEMSCI.2023.4.5

Abstract
  Atherosclerosis is the leading cause of death worldwide. It is now widely accepted that it is a chronic inflammatory process. Minor inflammation, increased oxidative stress, and lipid ...  Read More
Role of Kaempferol Combined with Pioglitazone in the Alleviation of Inflammation and Modulation of Necroptosis and Apoptosis Pathways in NASH-induced Mice
Role of Kaempferol Combined with Pioglitazone in the Alleviation of Inflammation and Modulation of Necroptosis and Apoptosis Pathways in NASH-induced Mice

Asmaa R. Abdel-Hamed; Amir O. Hamouda; Dina M. Abo-elmatty; Naglaa F. Khedr; Maivel H. Ghattas

Volume 6, Issue 2 , February 2023, , Pages 250-268

https://doi.org/10.26655/JMCHEMSCI.2023.2.8

Abstract
  Background: Nonalcoholic steatohepatitis (NASH) is one of the most serious health problems in the world. Apoptosis and necroptosis signaling pathways are highly implicated in NASH. ...  Read More